Company news
Rockwell Medical, Inc. news in 2021
Rockwell Medical, Inc.'s news releases, calls and decks from 2021, newest first.
Rockwell Medical Receives Important Feedback from FDA on its IND Application for Phase 2 Trial of Ferric Pyrophosphate Citrate in Home Infusion
December 13, 2021
Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update
November 14, 2021
Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
November 10, 2021
Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
August 18, 2021
Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational Update
August 15, 2021
Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
June 27, 2021
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates
June 10, 2021
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey
June 7, 2021
Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update
May 16, 2021
Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada
April 26, 2021
Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update
March 30, 2021
Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021
March 17, 2021
Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis
February 8, 2021
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
January 31, 2021
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China
January 12, 2021